Search Within

GDMT, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (239)
  2. Meeting Abstract (141)
  3. Editorial (3)
  4. Book Section (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Department of Medicine (386)
  2. Epidemiology and Biostatistics (386)
  3. Gynecology Disease Management Team (386)
  4. Solid Tumor Oncology Division (382)
  5. Gynecologic Medicine Service (366)
  6. Biostatistics Service (314)

More Groups

People
  1. Alexia Iasonos (186)
  2. Carol Aghajanian (163)
  3. Qin Zhou (143)
  4. Nadeem Abu-Rustum (87)
  5. Dennis Chi (85)
  6. Martee Hensley (83)

More People

Years
  1. 2025 (10)
  2. 2024 (28)
  3. 2023 (34)
  4. 2022 (44)
  5. 2021 (27)
  6. 2020 (33)

More Years

Publications
  1. Gynecologic Oncology (92)
  2. Journal of Clinical Oncology (90)
  3. International Journal of Gynecological Cancer (37)
  4. Clinical Cancer Research (14)
  5. Cancer (12)
  6. Cancer Research (11)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (100)
  3. Lippincott Williams & Wilkins (39)
  4. American Association for Cancer Research (36)
  5. Nature Publishing Group (16)
  6. Wiley Blackwell (16)

More Publishers

Results (386)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA)
    Meeting Abstract

    Berman, B.; Konner, J.; Belum, V. R.; Dion, H.; Ciccolini, K.; Kitts, S.; Ye, R.; Ravipaty, S.; Akmaev, V. R.; Sarangarajan, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Intestinal microbiota and relapse after hematopoietic-cell transplantation
    Journal Article

    Peled, J. U.; Devlin, S. M.; Staffas, A.; Lumish, M.; Khanin, R.; Littmann, E. R.; Ling, L. L.; Kosuri, S.; Maloy, M.; Slingerland, J. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Survival of patients with serous uterine carcinoma undergoing sentinel lymph node mapping
    Journal Article

    Schiavone, M. B.; Scelzo, C.; Straight, C.; Zhou, Q.; Alektiar, K. M.; Makker, V.; Soslow, R. A.; Iasonos, A.; Leitao, M. M.; Abu-Rustum, N. R.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save